SCHEMBL29626004

SCHEMBL29626004

CN1CCN(Cc2cnc(N)cc2C(F)(F)F)CC1

nearest known ligand 0.63

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.63
KDM4E B2RXH2 1/20 0.49
ALDH1A1 P00352 1/20 0.49
POLB P06746 1/20 0.49
KIT P10721 7/20 0.45
ABL1 P00519 3/20 0.45
ABL2 P42684 1/20 0.45
EGFR P00533 2/20 0.45
BRAF P15056 2/20 0.45
RET P07949 1/20 0.44
CDK1 P06493 1/20 0.43
CDK2 P24941 1/20 0.43
CDK8 P49336 1/20 0.43
NTRK1 P04629 1/20 0.42
NTRK3 Q16288 1/20 0.42
NTRK2 Q16620 1/20 0.42
SRC P12931 2/20 0.41
FGFR4 P22455 1/20 0.41
DHFR P00374 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20214361 1.00 NR1H2 (0.63) NR1H2KDM4EALDH1A1POLBKIT
SCHEMBL24534055 0.79 NR1H2 (0.51) NR1H2KDM4EALDH1A1POLBKIT
SCHEMBL29493475 0.77 NR1H2 (1.00) NR1H2KDM4EALDH1A1POLBKIT
SCHEMBL273351 0.77 NR1H2 (1.00) NR1H2KDM4EALDH1A1POLBKIT
SCHEMBL24534127 0.77 NR1H2 (0.49) NR1H2KDM4EALDH1A1POLBKIT
SCHEMBL17593244 0.76 NR1H2 (0.64) NR1H2KDM4EALDH1A1POLBKIT
SCHEMBL22165520 0.75 PIK3CA (0.43) NR1H2ALDH1A1CDK2
SCHEMBL21465752 0.75 NR1H2 (0.59) NR1H2KDM4EALDH1A1POLBKIT
SCHEMBL24534052 0.74 CNR2 (0.54) NR1H2KITABL1EGFRBRAF
SCHEMBL18753652 0.74 ALDH1A1 (0.58) NR1H2KDM4EALDH1A1POLBKIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4263521-A1 PYRAZOLE DERIVATIVES AS C-ABL INHIBITORS BenevolentAI Bio Limited (GB) 2023-10-25 EP disclosed
WO-2022129915-A1 PYRAZOLE DERIVATIVES AS C-ABL INHIBITORS BENEVOLENTAI BIO LIMITED (GB) 2022-06-23 WO disclosed